On Monday, Agilent Technologies Inc (NYSE:A)’s shares declined -0.80% to $39.52.
Agilent Technologies Inc. (NYSE:A) and Waters Corp. (WAT) recently declared a formal agreement to exchange instrument controls to improve the productivity of customers who own software and instruments from both companies.
The new agreement replaces earlier provisions under which Agilent implemented control of Waters instruments in the Agilent OpenLAB chromatography data system and Waters implemented control of Agilent liquid chromatography instruments in Waters Empower Software.
The newly signed agreement defines terms and conditions on how the companies will exchange instrument control documentation and driver software and how they will provide developer and technical support to one another. It also spells out the escalation mechanisms for resolving technical issues for their mutual customers.
Waters and Agilent first agreed to exchange instrument control codes in 1999. Over the years, technology exchange and vendor partnership have become increasingly important in the analytical instrument industry, as there are substantial benefits to the scientific community when they can control instruments from multiple vendors with their chromatography data software.
Agilent Technologies, Inc. provides bio-analytical solutions and services to the life sciences, diagnostics and genomics, chemical analysis, communications, and electronics industries worldwide. The companys Life Sciences and Diagnostics segment offers liquid chromatography systems, columns, and components; liquid chromatography mass spectrometry systems; laboratory software and informatics systems; laboratory automation and robotic systems; dissolution testing; nucleic acid solutions; nuclear magnetic resonance, magnetic resonance imaging, and X-ray diffraction systems; immunohistochemistry; in situ hybridization; hematoxylin and eosin staining; special staining, DNA mutation detection; genotyping; gene copy number determination; identification of gene rearrangements; DNA methylation and gene expression profiling; next generation sequencing target enrichment; and automated gel electrophoresis-based sample analysis systems.
Canadian National Railway (USA) (NYSE:CNI)’s shares gained 0.20% to $59.43.
Canadian National Railway (USA) (CNI) signed a memorandum of understanding (MOU) with the Alabama State Port Authority (ASPA), which owns the public terminals at the Port of Mobile, intended to drive raised supply chain efficiency and a greater share of transportation markets in North America.
A key signatory to CN’s MOU for the Port of Mobile gateway is APM Terminals Mobile, LLC. APM Terminals operates a 95-acre, deep-sea container terminal at the Port of Mobile. The state-of-the-art container terminal is adjacent to the intermodal rail facility now under construction. The ASPA is building the US$32-million rail terminal that will permit the direct and fluid transfer of containers between vessel and rail car in the spring of 2016.
Canadian National Railway Company, together with its auxiliaries, engages in rail and related transportation business in North America. It offers transportation services that comprise rail, intermodal container, and trucking services; and supply chain solutions, counting warehousing and distribution, cargoflo, logistics parks, freight forwarding, customs brokerage service, industrial development, and marine services.
At the end of Monday’s trade, 3M Co (NYSE:MMM)‘s shares dipped -1.38% to $155.86.
3M Co (NYSE:MMM) and Catheter Connections Inc. declared recently that they have settled the patent infringement litigation in the United States District Courts of California and Utah and at the United States Patent and Trademark Office between 3M’s newly attained Ivera Medical Corp. and Catheter Connections Inc. The settlement relates to disinfecting port protector intellectual property, counting Catheter Connections’ DualCap System™ products and 3M™ Curos™ products and resolves all disputes between the two parties. The specific terms of the settlement are confidential.
In a joint statement the two companies commented, “This agreement between 3M and Catheter Connections ends the legal disputes between our two companies and enables each company to direct its full energies toward further innovation and development in the market for products that disinfect and protect devices used for accessing the patient’s bloodstream.”
3M Company operates as a diversified technology company worldwide. Its Industrial segment offers tapes; coated, non-woven, and bonded abrasives; adhesives; ceramics; sealants; specialty materials; filtration products; closure systems for personal hygiene products; acoustic systems products; automotive components; abrasion-resistant films; structural adhesives; and paint finishing and detailing products.
Yelp Inc (NYSE:YELP), ended its Monday’s trading session with -0.09% loss, and closed at $44.00.
Blue Calypso, Inc. developer of patented mobile consumer shopping engagement solutions for retailers and product manufacturers, recently declared the Court has reset a Claim Construction Hearing, or “Markman hearing” for July 8, 2015 in the Eastern District of Texas for Blue Calypso’s patent infringement lawsuits against Groupon , Foursquare, Yelp (YELP) and IZEA. The hearing had been planned for Jun 29, 2015. Judge Rodney Gilstrap will preside.
Yelp Inc. operates a platform that connects people with local businesses in the United States. Its platform covers various local business categories, counting restaurants, shopping, beauty and fitness, arts, entertainment and events, home and local services, health, nightlife, travel and hotel, auto, and others categories.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
